By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Jefferies has raised its revenue estimates for Complete Genomics for full-year 2011 and 2012, following the firm's presentation Friday morning at the Future Leaders in Biotech Industry Conference today in New York.

Jefferies analyst Jon Wood also raised his price target on the firm's stock to $15.50 from $13, and retained his "Buy" rating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.